Looks like Biocurex has learned some vaulable lessons over the past few months, regarding the folks they are dealing with. Everyone keeps blaming smithline, for all we know the licensee's could be behind some of the price manipulation, I would hope Biocurex would at least file a complaint with the SEC.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.